Search Results - "Harris, Dwight D"

Refine Results
  1. 1

    Dipeptidyl peptidase 4 inhibitor sitagliptin decreases myocardial fibrosis and modulates myocardial insulin signaling in a swine model of chronic myocardial ischemia by Harris, Dwight D, Sabe, Sharif A, Broadwin, Mark, Stone, Chris, Bellam, Krishna, Malhotra, Akshay, Abid, M Ruhul, Sellke, Frank W

    Published in PloS one (29-07-2024)
    “…Although both clinical data and animal models suggest cardiovascular benefits following administration of Dipeptidyl Peptidase 4 (DPP-4) inhibitors, the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Left Ventricular Assist Device Outflow Graft Obstruction: A Complication Specific to Polytetrafluoroethylene Covering. A Word of Caution by Alnabelsi, Talal, Shafii, Alexis E, Gurley, John C, Dulnuan, Kenneth, Harris, Dwight D, Guglin, Maya

    Published in ASAIO journal (1992) (01-08-2019)
    “…Pump thrombosis is an established complication of left ventricular assist devices (LVADs). Outflow graft obstruction has been previously described as one cause…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Role of Protein Kinase C in Metabolic Regulation of Coronary Endothelial Small Conductance Calcium-Activated Potassium Channels by Xing, Hang, Sabe, Sharif A, Shi, Guangbin, Harris, Dwight D, Liu, Yuhong, Sellke, Frank W, Feng, Jun

    Published in Journal of the American Heart Association (06-02-2024)
    “…Small conductance calcium-activated potassium (SK) channels are largely responsible for endothelium-dependent coronary arteriolar relaxation. Endothelial SK…”
    Get full text
    Journal Article
  6. 6

    Antineutrophil Cytoplasmic Antibody Vasculitis after Coronary Artery Bypass Grafting by Harris, Dwight D, Sabe, Sharif A, Ehsan, Afshin

    Published in Case reports in surgery (2024)
    “…Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a group of rare autoimmune disorders associated with the presence of ANCA autoantibodies…”
    Get full text
    Journal Article
  7. 7

    DPP-4 inhibitor sitagliptin treatment results in altered myocardial metabolic proteome and oxidative phosphorylation in a swine model of chronic myocardial ischemia by Harris, Dwight D, Sabe, Sharif A, Broadwin, Mark, Bellam, Krishna, Xu, Cynthia M, Li, Janelle W, Abid, M Ruhul, Sellke, Frank W

    Published in Physiological reports (01-03-2024)
    “…Small animal models have shown improved cardiac function with DPP-4 inhibition, but many human studies have shown worse outcomes or no benefit. We seek to…”
    Get full text
    Journal Article
  8. 8

    Impaired cardiac glycolysis and glycogen depletion are linked to poor myocardial outcomes in juvenile male swine with metabolic syndrome and ischemia by Broadwin, Mark, Harris, Dwight D., Sabe, Sharif A., Sengun, Elif, Sylvestre, Amber J., Alexandrov, Boian S., Sellke, Frank W., Usheva, Anny

    Published in Physiological reports (01-08-2023)
    “…Obesity continues to rise in the juveniles and obese children are more likely to develop metabolic syndrome (MetS) and related cardiovascular disease…”
    Get full text
    Journal Article
  9. 9

    Crafting a Rigorous, Clinically Relevant Large Animal Model of Chronic Myocardial Ischemia: What Have We Learned in 20 Years? by Stone, Christopher R, Harris, Dwight D, Broadwin, Mark, Kanuparthy, Meghamsh, Sabe, Sharif A, Xu, Cynthia, Feng, Jun, Abid, M Ruhul, Sellke, Frank W

    Published in Methods and protocols (01-02-2024)
    “…The past several decades have borne witness to several breakthroughs and paradigm shifts within the field of cardiovascular medicine, but one component that…”
    Get full text
    Journal Article
  10. 10

    Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial Ischemia by Harris, Dwight D, Sabe, Sharif A, Broadwin, Mark, Stone, Christopher, Xu, Cynthia, Hu, Jiayu, Kanuparthy, Meghamsh, Abid, M Ruhul, Sellke, Frank W

    Published in Biomedicines (01-03-2024)
    “…Sodium-glucose cotransporter-2 (SGLT2) inhibitors are known to be cardioprotective independent of glucose control, but the mechanisms of these benefits are…”
    Get full text
    Journal Article
  11. 11

    Intramyocardial Injection of Hypoxia-Conditioned Extracellular Vesicles Modulates Response to Oxidative Stress in the Chronically Ischemic Myocardium by Harris, Dwight D, Sabe, Sharif A, Broadwin, Mark, Xu, Cynthia, Stone, Christopher, Kanuparthy, Meghamsh, Malhotra, Akshay, Abid, M Ruhul, Sellke, Frank W

    Published in Bioengineering (Basel) (01-01-2024)
    “…Patients with advanced coronary artery disease (CAD) who are not eligible for stenting or surgical bypass procedures have limited treatment options…”
    Get full text
    Journal Article
  12. 12

    Effects of canagliflozin on myocardial microvascular density, oxidative stress, and proteomic profile by Sabe, Sharif A., Xu, Cynthia M., Sabra, Mohamed, Harris, Dwight D., Broadwin, Mark, Bellam, Krishna G., Banerjee, Debolina, Usheva, Anny, Abid, M. Ruhul, Sellke, Frank W.

    “…Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are cardioprotective, and canagliflozin (CANA), an SGLT2i, has been shown to improve perfusion, AMPK…”
    Get full text
    Journal Article
  13. 13

    Extracorporeal membrane oxygenation as a rescue measure after thoracic surgery by Harris, Dwight D, Saha, Sibu P

    Published in Asian cardiovascular & thoracic annals (01-03-2018)
    “…Background Extracorporeal membrane oxygenation is used for many different conditions including respiratory distress, cardiogenic shock, and trauma. In these…”
    Get full text
    Journal Article
  14. 14

    Increased blood transfusion and its impact in patients having tracheostomy while on extracorporeal membrane oxygenation by Harris, Dwight D., Shafii, Alexis E., Baz, Maher, Tribble, Thomas A., Ferraris, Victor A.

    Published in Perfusion (01-03-2019)
    “…Introduction: Tracheostomy has been utilized in combination with venovenous extracorporeal membrane oxygenation (VV-ECMO) to enable early spontaneous breathing…”
    Get full text
    Journal Article
  15. 15

    Cardioprotection in cardiovascular surgery by Sabe, Sharif A., Harris, Dwight D., Broadwin, Mark, Sellke, Frank W.

    Published in Basic research in cardiology (01-08-2024)
    “…Since the invention of cardiopulmonary bypass, cardioprotective strategies have been investigated to mitigate ischemic injury to the heart during aortic…”
    Get full text
    Journal Article
  16. 16

    Gender, race, and ethnicity in lung cancer clinical trial participation: Analysis of 253,845 patients from 2002 to 2021 by Kanuparthy, Meghamsh, Kanuparthy, Srikur, Harris, Dwight D., Broadwin, Mark, Stone, Christopher, Abbas, Abbas E., Sellke, Frank W.

    “…Lung cancer remains the greatest cause of cancer-related death, and multiple large studies have identified persistent racial disparities in lung cancer…”
    Get full text
    Journal Article
  17. 17

    Metformin Preconditioning Augments Cardiac Perfusion and Performance in a Large Animal Model of Chronic Coronary Artery Disease by Stone, Christopher, Sabe, Sharif, Harris, Dwight D, Broadwin, Mark, Kant, Rajeev, Kanuparthy, Meghamsh, Abid, M Ruhul, Sellke, Frank W

    Published in Annals of surgery (01-10-2024)
    “…To test the efficacy of metformin during the induction of coronary ischemia on myocardial performance in a large animal model of coronary artery disease (CAD)…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Canagliflozin improves coronary microvascular vasodilation and increases absolute blood flow to the myocardium independent of angiogenesis by Banerjee, Debolina, Sabe, Sharif A, Xing, Hang, Xu, Cynthia, Sabra, Mohamed, Harris, Dwight D, Broadwin, Mark, Abid, M Ruhul, Usheva, Anny, Feng, Jun, Sellke, Frank W

    “…Sodium-glucose cotransporter-2 inhibitor, canagliflozin, improves myocardial perfusion to ischemic territory without accompanying changes in vascular density…”
    Get full text
    Journal Article